Sarah Harden
Dr. Sarah L. Harden earned her PhD in Molecular Biomedicine from the University of Warwick in 2023. During her research time she spent two years at The Agency of Science and Technology Research in Singapore and collaborated with the Singapore-MIT Alliance for Research and Technology. Her research focused on the metabolic regulation of endometrial stromal cell decidualization and its link to recurrent miscarriage, providing valuable insights into reproductive health mechanisms. She further investigated the interplay between autoimmunity and endometriosis, contributing to a deeper understanding of this complex disorder and proposing improved diagnostic and treatment strategies.
Following her PhD, Dr. Harden joined EndoGene.Bio as a Research Associate to bridge research and patient care. At EndoGene.Bio, she is focusing her efforts on developing a method that will allow for early diagnosis of endometriosis, as well as on patient stratification for targeted treatments, therefore making a direct impact to women’s health.
Dr. Harden is committed to mentoring future scientists and communicating her research to various audiences. In 2023 she launched a website (www.sarahlharden.weebly.com) to explain complex scientific topics related to women’s health using scientific illustrations and accessible writing.
Through her work Dr. Harden aims to advance women’s health and make a real-world difference in patients’ lives.
Dr. Sarah L. Harden is a highly motivated scientist committed to advancing women’s health. She earned her PhD in Molecular Biomedicine from the University of Warwick in 2023, focusing on metabolic regulation in endometrial stromal cells and its link to recurrent miscarriage. She, additionally, explored the interplay between autoimmunity and endometriosis. Dr. Harden is a passionate scientific communicator and a dedicated mentor for future scientists.
She currently works as a Research Associate at EndoGene.Bio, a scientifically driven company that is determined to shorten the journey to endometriosis diagnosis for millions of women and to develop patient stratification strategies that will pave the way for efficient personalized treatments.